{"meta":{"query_hash":"ae66f543bf4a","filters":{"venue":"Clinical and Translational Discovery"},"cohort_total":9,"direct_labels_cover":0,"predictions_cover":9,"exported":9,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ae66f543bf4a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+and+Translational+Discovery"},"results":[{"id":"W4281691501","doi":"10.1002/ctd2.40","title":"Overview of recent advances in Vero cells genomic characterization and engineering for high‐throughput vaccine manufacturing","year":2022,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Vero cell; Virology; Bioprocess; Biology; Cell culture; Virus; Genetics","score_opus":0.0235398614249051,"score_gpt":0.30479973201728777,"score_spread":0.28125987059238267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281691501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008331864,0.91264313,0.065843396,0.001335511,0.0006850883,0.00020934302,0.00064956944,0.00044014,0.009861946],"genre_scores_gemma":[0.030698892,0.912694,0.04958115,0.0006946184,0.00055054243,0.00021866967,0.001773847,0.0001325507,0.0036557019],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998887,0.00024748113,0.00015268114,0.00019833264,0.00044026325,0.00007434332],"domain_scores_gemma":[0.99858826,0.00069862994,0.000235866,0.00009046148,0.0003312887,0.000055539844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020836398,0.0011014563,0.0012422926,0.0023949177,0.00029843947,0.0022433365,0.00090371456,0.001071933,0.0019555665],"category_scores_gemma":[0.0014354159,0.00073255575,0.0012941677,0.002072896,0.0005180844,0.001591504,0.0007507781,0.0017600785,0.0017252048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018961876,0.00022012237,0.00089590583,0.025872504,0.00019691826,0.0005918623,0.00035304113,0.0037788623,0.2823731,0.011327136,0.011430542,0.6627704],"study_design_scores_gemma":[0.000026710037,0.00062670687,0.0019576345,0.0016235993,0.00030906068,0.0016412807,0.00015097772,0.0030732441,0.17855076,0.0042551127,0.80764186,0.00014301919],"about_ca_topic_score_codex":0.000773316,"about_ca_topic_score_gemma":0.0007572215,"teacher_disagreement_score":0.0023949177,"about_ca_system_score_codex":0.0008699492,"about_ca_system_score_gemma":0.0009428873,"threshold_uncertainty_score":0.011019468},"labels":[],"label_agreement":null},{"id":"W4281761878","doi":"10.1002/ctd2.90","title":"MicroRNA‐200c overexpression in cancer‐associated fibroblasts decreases interleukin‐2 secretion","year":2022,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Isfahan University of Medical Sciences","keywords":"Lipofectamine; Transfection; Secretion; Fibroblast; Chemistry; Molecular biology; Interleukin; Cancer-Associated Fibroblasts; Biology; Cancer; Cancer cell; Cytokine; Internal medicine; Endocrinology; Immunology; Medicine; Biochemistry; In vitro; Gene","score_opus":0.02173926196895268,"score_gpt":0.313464854498288,"score_spread":0.2917255925293353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281761878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916794,0.002242729,0.0028949252,0.00015080372,0.00013341905,0.00004491684,0.00036715917,0.0001930631,0.002293499],"genre_scores_gemma":[0.9940236,0.0008047019,0.0024285251,0.00010075359,0.000021908907,0.00009644637,0.00047688602,0.000022687584,0.00202438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982834,0.00003809707,0.00002051204,0.000027008118,0.00005068685,0.00003540835],"domain_scores_gemma":[0.9998863,0.00003622256,0.000021431171,0.0000133916665,0.00001712776,0.000025491561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016800704,0.00025001768,0.00023812699,0.0002450667,0.0001549806,0.00026478688,0.00011356624,0.000239545,0.0013494489],"category_scores_gemma":[0.00020887991,0.00012096828,0.00019191908,0.00015288302,0.00015306448,0.0001222353,0.00010585721,0.0003762035,0.00037919093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013974521,0.000032539225,0.000118182244,0.000027330494,0.0000030085844,0.00003523742,0.000009479375,0.000016783479,0.998879,0.000029522971,0.000063797175,0.00064536085],"study_design_scores_gemma":[0.000030877833,0.00043258566,0.0028938665,0.0000054029438,0.00001648398,0.00026579606,0.000026046264,0.00093441084,0.993056,0.000027688871,0.0023069938,0.000003933703],"about_ca_topic_score_codex":0.00040619576,"about_ca_topic_score_gemma":0.0005020495,"teacher_disagreement_score":0.0013494489,"about_ca_system_score_codex":0.00017970506,"about_ca_system_score_gemma":0.00020082197,"threshold_uncertainty_score":0.0045143366},"labels":[],"label_agreement":null},{"id":"W4384407311","doi":"10.1002/ctd2.205","title":"Profiling of circulating serum exosomal microRNAs in elderly patients with infectious stress hyperglycaemia","year":2023,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto","funders":"Banting and Best Diabetes Centre, University of Toronto; Basic and Applied Basic Research Foundation of Guangdong Province; University of Toronto; National Natural Science Foundation of China; Natural Science Foundation of Shenzhen City","keywords":"Cohort; Medicine; microRNA; Internal medicine; Disease; Exosome; Cohort study; Coronavirus disease 2019 (COVID-19); Logistic regression; Oncology; Bioinformatics; Microvesicles; Infectious disease (medical specialty); Biology; Gene","score_opus":0.01260874511101238,"score_gpt":0.2734294441525424,"score_spread":0.26082069904153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384407311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740833,0.0010104785,0.00075677363,0.00002589058,0.000017701159,0.000016016484,0.00042127346,0.000015747522,0.00032780535],"genre_scores_gemma":[0.9980652,0.00029751085,0.00080667477,0.00006904157,0.000022406562,0.000026299209,0.00046621216,0.000005466408,0.00024128528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997161,0.00006410666,0.000048859525,0.00008238101,0.00005190951,0.000036558304],"domain_scores_gemma":[0.9995041,0.0001437335,0.00016215474,0.000027579648,0.00011226905,0.000050177274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043428363,0.0003201899,0.0004170658,0.00057254004,0.00020870371,0.00060162885,0.00012401491,0.00033434265,0.0006841935],"category_scores_gemma":[0.0013303536,0.0001617266,0.00025239456,0.0004517081,0.00012779488,0.00018208356,0.00030710062,0.00027153076,0.00020936863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023904485,0.000113808164,0.9215527,0.00018996584,0.00021489275,0.00085944275,0.0004734569,0.00033409844,0.054100353,0.000077401906,0.0004438559,0.01924958],"study_design_scores_gemma":[0.00004806248,0.0011021912,0.9700033,0.00005536961,0.00027166452,0.0028512112,0.00067119964,0.0028404894,0.0200524,0.00017702601,0.001897284,0.000029702893],"about_ca_topic_score_codex":0.00029793146,"about_ca_topic_score_gemma":0.00029863275,"teacher_disagreement_score":0.0006841935,"about_ca_system_score_codex":0.000118634474,"about_ca_system_score_gemma":0.00010775981,"threshold_uncertainty_score":0.0022967458},"labels":[],"label_agreement":null},{"id":"W4385794587","doi":"10.1002/ctd2.227","title":"Lymph node metastasis in oral squamous cell carcinoma: Where we are and where we are going","year":2023,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Immunotherapy; Neck dissection; Lymph node; Metastasis; Oncology; Cancer; Dissection (medical); Clinical trial; Radiology; Internal medicine","score_opus":0.0705476701719316,"score_gpt":0.34323206320238137,"score_spread":0.2726843930304498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385794587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048810537,0.9795902,0.0013269547,0.009451897,0.0014662619,0.000020269845,0.00014636158,0.00002985618,0.003087115],"genre_scores_gemma":[0.060636383,0.9276542,0.0018188264,0.004741838,0.0025273599,0.000038491773,0.00031379468,0.000017493217,0.002251646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926955,0.00023417117,0.0001128134,0.00013815386,0.0001681452,0.000077167046],"domain_scores_gemma":[0.99896693,0.0004648532,0.00017325245,0.000025544356,0.0002847143,0.000084653715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009583886,0.00038298572,0.0007270676,0.0010684849,0.00049773103,0.0019941537,0.00061421783,0.001329781,0.0029291874],"category_scores_gemma":[0.0026605523,0.00019140229,0.0007058901,0.0011234334,0.0009596623,0.0026228253,0.000804578,0.0016866567,0.0007230214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049865275,0.000078452875,0.020534381,0.02068511,0.0002733674,0.002067856,0.0018285986,0.0008043325,0.0041384227,0.016969817,0.05880516,0.87331593],"study_design_scores_gemma":[0.000051653828,0.00040753142,0.034129616,0.025519593,0.00066948024,0.0140944095,0.005531773,0.0011633007,0.0029508248,0.025840227,0.88944197,0.00019968991],"about_ca_topic_score_codex":0.0033199955,"about_ca_topic_score_gemma":0.0043216585,"teacher_disagreement_score":0.0033199955,"about_ca_system_score_codex":0.0008976011,"about_ca_system_score_gemma":0.0016628016,"threshold_uncertainty_score":0.009799063},"labels":[],"label_agreement":null},{"id":"W4403174248","doi":"10.1002/ctd2.70009","title":"Developing messenger RNA biomarkers: A workflow to characterise and identify transcript target sequences unaffected by alternative splicing for reproducible gene transcript quantification by reverse transcriptase quantitative polymerase chain reaction","year":2024,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Reverse transcriptase; RNA splicing; Biology; Messenger RNA; Gene; Alternative splicing; Mature messenger RNA; Computational biology; RNA; Post-transcriptional modification; Genetics","score_opus":0.05534122912123656,"score_gpt":0.375574750912204,"score_spread":0.3202335217909674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403174248","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02295604,0.0006523512,0.9605688,0.0002102798,0.00020113491,0.0014867514,0.0035047506,0.0089382725,0.0014815399],"genre_scores_gemma":[0.031419195,0.00050354004,0.95685303,0.00036082297,0.000042687458,0.0038826307,0.0034153531,0.0009649777,0.0025577557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99649256,0.0006165118,0.00039209743,0.0012192884,0.001025215,0.00025427694],"domain_scores_gemma":[0.9972945,0.0011585008,0.00044610034,0.00037901427,0.00057797704,0.00014392215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041233986,0.00243521,0.0017612913,0.0030247618,0.00094472483,0.0023192435,0.0013525615,0.0018031449,0.0046217525],"category_scores_gemma":[0.003906866,0.0016377346,0.0019544417,0.0012275786,0.0015023391,0.00097287423,0.0011445404,0.0027211923,0.006983364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002442354,0.000086645596,0.0006150621,0.0003464439,0.00003800269,0.00017733614,0.0001137848,0.000746702,0.9820931,0.0013941412,0.0011277966,0.013016711],"study_design_scores_gemma":[0.00007664179,0.000333984,0.0011207992,0.0000727387,0.000056625406,0.0003819699,0.000047091453,0.010298239,0.9685532,0.0021113313,0.01684648,0.000100898054],"about_ca_topic_score_codex":0.00046124496,"about_ca_topic_score_gemma":0.0008763908,"teacher_disagreement_score":0.0046217525,"about_ca_system_score_codex":0.0008582036,"about_ca_system_score_gemma":0.0019165328,"threshold_uncertainty_score":0.021806896},"labels":[],"label_agreement":null},{"id":"W4406043541","doi":"10.1002/ctd2.70028","title":"The FACTs trial for Fabry disease highlights the promise and challenges of gene therapy","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Fabry disease; Genetic enhancement; Disease; Medicine; Clinical trial; Intensive care medicine; Genetics; Gene; Biology; Internal medicine","score_opus":0.11327105626559682,"score_gpt":0.39222756544341353,"score_spread":0.2789565091778167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406043541","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47512385,0.2889983,0.018544406,0.14941268,0.0077582328,0.0012726058,0.0024949894,0.0007804854,0.05561453],"genre_scores_gemma":[0.81197816,0.09774818,0.015228593,0.035431717,0.006531795,0.0007195027,0.0025744324,0.00020400573,0.029583614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989291,0.0005518938,0.000053050386,0.00008503565,0.00028492816,0.00009605469],"domain_scores_gemma":[0.99884844,0.0007195559,0.000117488315,0.000052170035,0.000085876476,0.00017638582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038529837,0.0003345834,0.00076095626,0.00025766421,0.0002494334,0.0013867584,0.00036601615,0.0020500557,0.004924263],"category_scores_gemma":[0.002066823,0.000082283375,0.0006287415,0.00029522242,0.00056768704,0.0011047429,0.00041569446,0.0024930134,0.00091449864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04168499,0.0018893308,0.0035197914,0.0016654185,0.0005533806,0.002085664,0.0003659723,0.0032419157,0.038494512,0.035849653,0.049166594,0.82148284],"study_design_scores_gemma":[0.037413854,0.09435652,0.018202182,0.0013771476,0.0008801648,0.0052462528,0.00038690763,0.005294797,0.01751027,0.024239209,0.7949327,0.0001600054],"about_ca_topic_score_codex":0.00066115876,"about_ca_topic_score_gemma":0.0016407719,"teacher_disagreement_score":0.004924263,"about_ca_system_score_codex":0.0005261212,"about_ca_system_score_gemma":0.0005614951,"threshold_uncertainty_score":0.020376742},"labels":[],"label_agreement":null},{"id":"W4408377438","doi":"10.1002/ctd2.70042","title":"Towards a one‐time cure for Fabry disease: Lentivirus‐mediated haematopoietic stem and progenitor cell gene therapy","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Haematopoiesis; Genetic enhancement; Progenitor cell; Lentivirus; Stem cell; Disease; Biology; Gene; Virology; Medicine; Immunology; Cancer research; Genetics; Internal medicine; Human immunodeficiency virus (HIV); Viral disease","score_opus":0.05765890817216945,"score_gpt":0.35705818515470394,"score_spread":0.2993992769825345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408377438","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16025656,0.6084615,0.13713306,0.043741945,0.0062294207,0.0014531277,0.0009220712,0.0016571991,0.040145103],"genre_scores_gemma":[0.5244414,0.30564034,0.09647499,0.034440503,0.004170729,0.00097456435,0.0016211874,0.00028139201,0.031954914],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997409,0.0000632735,0.000016812868,0.00003382303,0.00010428386,0.0000409709],"domain_scores_gemma":[0.9998167,0.00006671682,0.000036250447,0.000013291115,0.000023927681,0.000043066084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011519426,0.0005081415,0.0006141558,0.0007093144,0.0002487952,0.0011237224,0.000709356,0.0011102876,0.0034664054],"category_scores_gemma":[0.00062239595,0.00016038271,0.00038392408,0.00033572264,0.00080694514,0.0010506585,0.00051272026,0.0028101585,0.0009668547],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026088406,0.003047023,0.0018295402,0.0019791764,0.00046038232,0.0027921165,0.00039963672,0.0026455023,0.1299567,0.08041533,0.042426456,0.7314394],"study_design_scores_gemma":[0.0050601345,0.010132843,0.005331474,0.0019580063,0.0006929776,0.010964671,0.00029552597,0.010181038,0.07436602,0.043083392,0.83776736,0.00016666933],"about_ca_topic_score_codex":0.0003119183,"about_ca_topic_score_gemma":0.00061387697,"teacher_disagreement_score":0.0034664054,"about_ca_system_score_codex":0.00074734254,"about_ca_system_score_gemma":0.00040888126,"threshold_uncertainty_score":0.011596262},"labels":[],"label_agreement":null},{"id":"W4408384398","doi":"10.1002/ctd2.70038","title":"Commentary on ‘Lentivirus‐mediated gene therapy for Fabry disease: 5‐year end‐of‐study results from the Canadian FACTS trial’","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fondazione Telethon; European Commission","keywords":"Genetic enhancement; Lentivirus; Medicine; Fabry disease; Virology; Clinical trial; Disease; Oncology; Gene; Pediatrics; Genetics; Biology; Internal medicine; Human immunodeficiency virus (HIV); Viral disease","score_opus":0.08319845578048332,"score_gpt":0.387003429268415,"score_spread":0.3038049734879317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408384398","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063880463,0.014023551,0.0005472423,0.8794189,0.099095255,0.00016746418,0.0015625786,0.00017044855,0.0043757865],"genre_scores_gemma":[0.003390717,0.0042283293,0.0005474274,0.9210261,0.0661742,0.00018439721,0.00048761387,0.000075645214,0.0038855413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900045,0.0038560128,0.0012623601,0.00093007484,0.003114921,0.0008321821],"domain_scores_gemma":[0.95238554,0.030608265,0.002027268,0.00090667844,0.010825044,0.0032471865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017958235,0.0013753021,0.0030974462,0.0010804351,0.002053134,0.0033773652,0.004936624,0.02754736,0.0073792012],"category_scores_gemma":[0.0495416,0.00077635254,0.003693223,0.0016146385,0.0023901192,0.003058506,0.0010915353,0.020856654,0.0049846317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087203097,0.000017675888,0.0001607473,0.0004255814,0.000093392264,0.00015145463,0.000039937873,0.0000964303,0.00018928996,0.00074643124,0.9831255,0.014081425],"study_design_scores_gemma":[0.0019996245,0.00035265458,0.0017650976,0.0019172584,0.0004910995,0.00031152333,0.00007407708,0.00041454585,0.00040304006,0.0033790988,0.9887422,0.00014997085],"about_ca_topic_score_codex":0.024448205,"about_ca_topic_score_gemma":0.041295495,"teacher_disagreement_score":0.9755518,"about_ca_system_score_codex":0.006966147,"about_ca_system_score_gemma":0.0090782745,"threshold_uncertainty_score":0.094973385},"labels":[],"label_agreement":null},{"id":"W4411532226","doi":"10.1002/ctd2.70064","title":"Therapeutic potential of the annexin A family in atherosclerosis","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Discovery","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Heart and Stroke Foundation of Canada","keywords":"Inflammation; Annexin; Cancer research; Apoptosis; Medicine; Endothelial dysfunction; Annexin A5; Annexin A2; Therapeutic approach; Bioinformatics; Immunology; Cell biology; Biology; Disease; Internal medicine; Flow cytometry; Biochemistry","score_opus":0.02105540759027744,"score_gpt":0.3015199610812025,"score_spread":0.28046455349092503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411532226","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073085474,0.98240733,0.0017481379,0.0015095717,0.001079046,0.000028410672,0.00005831921,0.00004600078,0.0058145835],"genre_scores_gemma":[0.056114163,0.9295999,0.0024675906,0.0012337359,0.0010018826,0.000053865686,0.00018402336,0.000010811239,0.009334054],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992526,0.000020536265,0.0000082027755,0.000011071058,0.000024670559,0.00001022669],"domain_scores_gemma":[0.9999379,0.000019329847,0.000011331032,0.0000019057818,0.000019300596,0.000010176463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022192195,0.00033392408,0.00029437672,0.0004937391,0.00014802649,0.0005104688,0.00022500749,0.0005731371,0.0022347982],"category_scores_gemma":[0.00017712524,0.00006611094,0.00019842605,0.0002545034,0.00016534331,0.00038260964,0.00032821606,0.00089968165,0.0008536112],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006014802,0.0002719043,0.000521948,0.006198209,0.0001123121,0.00090387894,0.00010266254,0.0006039063,0.11552736,0.014050216,0.030183801,0.8309223],"study_design_scores_gemma":[0.0001080879,0.0007924296,0.001188259,0.00063207705,0.000095061216,0.0026402357,0.000062904895,0.00048242815,0.026544075,0.004630714,0.96280354,0.00002021578],"about_ca_topic_score_codex":0.00018418103,"about_ca_topic_score_gemma":0.00033061448,"teacher_disagreement_score":0.0022347982,"about_ca_system_score_codex":0.0002740089,"about_ca_system_score_gemma":0.00027053332,"threshold_uncertainty_score":0.0074760914},"labels":[],"label_agreement":null}]}